Clinical Trial Update: Effect of Angiotensin Converting Enzyme Inhibitor, Lisinopril, on Renal Blood Flow and Its Correlation With Proteinuria Reduction in Subjects With Type 2 Diabetes and Kidney Disease [NA]

View source ↗

Summary

This clinical trial evaluated the effect of lisinopril on renal blood flow and its relationship to proteinuria reduction in subjects with Type 2 diabetes and ki…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Lisinopril (Lisinopril)

Snippet

Sponsor: University of Virginia | Conditions: Type 2 Diabetes | NA | Status: TERMINATED